ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma

Biochem Biophys Res Commun. 1999 Jul 5;260(2):329-31. doi: 10.1006/bbrc.1999.0911.

Abstract

ICSAT (Interferon Consensus Sequence binding protein for Activated T cells) is a lymphocyte-specific member of the interferon regulatory factor (IRF) family of transcription factors, originally identified through Southwestern screening of the ATL(Adult T-cell leukemia)-16T expression library. In this study, we created transgenic mice overexpressing ICSAT in lymphocytes. Although spontaneous tumorigenesis was not observed, IL-2 production with Concanavalin A stimulation was significantly increased in transgenic mice overexpressing ICSAT. ICSAT overexpression in lymphocytes seems insufficient for the leukemogenesis of ATL or multiple myeloma (MM), however, it may regulate T cell activation and its overexpression may lead to leukemogenesis via controlling IL-2 production.

MeSH terms

  • Adult
  • Animals
  • Concanavalin A / pharmacology
  • DNA-Binding Proteins / genetics*
  • Humans
  • Immunoglobulin G / biosynthesis
  • Interferon Regulatory Factors
  • Interleukin-2 / biosynthesis
  • Leukemia, T-Cell / genetics*
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Mice
  • Mice, Transgenic
  • Multiple Myeloma / genetics*
  • Thymus Gland / cytology
  • Thymus Gland / drug effects
  • Thymus Gland / metabolism
  • Transcription Factors / genetics*

Substances

  • DNA-Binding Proteins
  • Immunoglobulin G
  • Interferon Regulatory Factors
  • Interleukin-2
  • Transcription Factors
  • interferon regulatory factor-4
  • Concanavalin A